Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.

RL Fine, AP Gulati, D Tsushima, KB Mowatt, A Oprescu… - 2014 - ascopubs.org
179 Background: We found in our lab that capecitabine (CAP), the prodrug of 5-FU, and
temozolomide (TEM) were synergistic in inducing apoptosis in BON neuroendocrine tumor (NET…

Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec®) in a patient being treated for gastrointestinal stromal tumor (GIST)

AP Gulati, MW Saif - Anticancer research, 2012 - ar.iiarjournals.org
Background: Gastrointestinal stromal tumor (GIST) is a mesenchymal malignancy of the
gastrointestinal tract. Imatinib mesylate (Gleevec®, ST1571, Novartis Pharmaceuticals, Basel, …

Is there a role for liver transplantation in metastatic pancreatic neuroendocrine tumors (PNET)?

AP Gulati, MW Saif - JOP. Journal of the Pancreas, 2012 - serena.unina.it
Dear Sir, recently, we published an important report on the role of radiotherapy in pancreatic
neuroendocrine tumors (PNET) consisting of our experience and the data presented at the …

Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).

AP Gulati, SM Schreibman, B Schrope, JA Lee… - 2014 - ascopubs.org
274 Background: Chemoradiation (CRT) is used in unresectable pancreatic cancer (PC) to
convert patients to a resectable state. Those who go to surgery can have a similar survival as …

Prospective phase II trial of GTX in metastatic pancreatic cancer: Laboratory and clinical studies.

R Fine, Y Lee, WH Sherman, AP Gulati, PE Oberstein… - 2013 - ascopubs.org
209 Background: We found that in pancreatic cancer (PC) cells, when gemcitabine, docetaxel,
capecitabine (GTX) are given in a sequence and time specific manner, it 1) increased Bax…

The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after …

PE Oberstein, AP Gulati, BA Krantz, RA Moss… - 2013 - ascopubs.org
308 Background: We have observed efficacy and tolerability of the CAPTEM regimen in
pNET. We conducted a retrospective review of patients with liver metastasis from any NET, …

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

…, D Flora, MD Galsky, MJ Glover, EA Griffiths, AP Gulati… - The Lancet, 2020 - thelancet.com
Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise
the outcomes of a cohort of patients with cancer and COVID-19 and identify potential …

Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19

…, TK Choueiri, DB Flora, EA Griffiths, AP Gulati… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …

Racial disparities in COVID-19 outcomes among black and white patients with cancer

…, AH Angevine, MH Bar, AP Gulati… - JAMA network …, 2022 - jamanetwork.com
Importance Non-Hispanic Black individuals experience a higher burden of COVID-19 than
the general population; hence, there is an urgent need to characterize the unique clinical …

Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19

…, C Labaki, P Grover, J Awosika, S Gulati… - JAMA …, 2023 - jamanetwork.com
Importance Cytokine storm due to COVID-19 can cause high morbidity and mortality and may
be more common in patients with cancer treated with immunotherapy (IO) due to immune …